(Q40463014)

20 September 2017

title

Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells. (English)

1 reference

20 September 2017

1 reference

0 references

Pratima Sur

1

1 reference

20 September 2017

Eric A Sribnick

2

1 reference

20 September 2017

Sunil J Patel

3

1 reference

20 September 2017

Swapan K Ray

4

1 reference

20 September 2017

Naren L Banik

5

1 reference

20 September 2017

publication date

1 April 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

50

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

160-167

1 reference

Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradation.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Dexamethasone inhibits the anti-tumor effect of interleukin 4 on rat experimental gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Involvement of the mismatch repair system in temozolomide-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Dexamethasone pre-treatment interferes with apoptotic death in glioma cells.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Mismatch correction at O 6 -methylguanine residues in E. coli DNA

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Dexamethasone-induced enhancement of resistance to ionizing radiation and chemotherapeutic agents in human tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

The Charing Cross Hospital experience with temozolomide in patients with gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Understanding and manipulating O6-methylguanine-DNA methyltransferase expression

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Rapid clinical deterioration in a patient with multi-focal glioma despite corticosteroid therapy: a quantitative MRI study

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Recurrent malignant glioma in adults.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Antitumor imidazotetrazines--XV. Role of guanine O6 alkylation in the mechanism of cytotoxicity of imidazotetrazinones

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Clinical management of brain metastasis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20168

7 January 2021

Identifiers

DOI

10.1002/GLIA.20168

1 reference

20 September 2017

1 reference